The periplasmic domain of FliP of the bacterial flagellar type III export apparatus has been expressed, purified and crystallized, and the crystals have been characterized by X-ray diffraction.
Keywords: FliP, type III export apparatus, bacterial flagellum, Thermotoga maritima
Abstract
The bacterial flagellar proteins are transported via a specific export apparatus to the distal end of the growing structure for their self-assembly. FliP is an essential membrane component of the export apparatus. FliP has an N-terminal signal peptide and is predicted to have four transmembrane (TM) helices and a periplasmic domain (FliPP) between TM-2 and TM-3. In this study, FliPP from Thermotoga maritima (TmFliPP) and its selenomethionine derivative (SeMet-TmFliPP) were purified and crystallized. TmFliPP formed a homotetramer in solution. Crystals of TmFliPP and SeMet-TmFliPP were obtained by the hanging-drop vapour-diffusion technique with 2-methyl-2,4-pentanediol as a precipitant. These two crystals grew in the hexagonal space group P6222 or P6422, with unit-cell parameters a = b = 114.9, c = 193.8 Å. X-ray diffraction data were collected from crystals of TmFliPP and SeMet-TmFliPP to 2.4 and 2.8 Å resolution, respectively.
1. Introduction
Many bacteria swim in liquid environments by rotating flagella, each of which consists of at least three parts: the basal body, the hook and the filament. Flagellar assembly begins with the basal body, followed by the hook and finally the filament. Most flagellar proteins are transported via the flagellar type III export apparatus to the distal end of the growing structure. The export apparatus consists of a membrane-embedded export gate consisting of FlhA, FlhB, FliO, FliP, FliQ and FliR, and a cytoplasmic ATPase complex consisting of FliH, FliI and FliJ. The export apparatus is located within the central pore of the basal body MS ring formed by 26 copies of FliF. FliG, FliM and FliN, which form the C ring on the cytoplasmic face of the MS ring, are required for efficient and rapid protein export. These proteins are highly homologous to those of the type III secretion systems of animal- and plant-pathogenic Gram-negative bacteria, which directly inject virulence factors into their host cells (Macnab, 2004 ▶; Minamino & Namba, 2004 ▶; Minamino et al., 2008 ▶; Minamino, 2013 ▶). Interestingly, the atomic structures of FliI and FliJ look similar to the α/β and γ subunits of FoF1-ATP synthase, respectively, suggesting an evolutionary relationship between the type III protein-export system and FoF1-ATP synthase (Imada et al., 2007 ▶; Ibuki et al., 2011 ▶; Kishikawa et al., 2013 ▶).
FlhA forms a nonameric ring structure in the export apparatus and requires FliO, FliP, FliQ and FliR for its oligomerization and subsequent assembly into the MS ring (Abrusci et al., 2013 ▶; Morimoto et al., 2014 ▶). The C-terminal cytoplasmic domain of FlhA (FlhAC) has been visualized at the centre of the cavity within the C ring (Abrusci et al., 2013 ▶; Kawamoto et al., 2013 ▶). FlhAC and the C-terminal cytoplasmic domain of FlhB (FlhBC) provide binding sites for the ATPase complex, flagellar chaperones and export substrates (Bange et al., 2010 ▶; Kinoshita et al., 2013 ▶; Minamino & Macnab, 2000 ▶; Minamino et al., 2003 ▶, 2008 ▶, 2011 ▶). Both FlhAC and FlhBC act as an export switch to coordinate flagellar protein export with assembly (Hirano et al., 2009 ▶; Kinoshita et al., 2013 ▶). A specific interaction of FliJ with FlhA brought about by FliH and FliI allows the export gate to utilize only the electric potential difference part (Δψ) of the proton motive force across the cytoplasmic membrane to drive protein translocation (Minamino & Namba, 2008 ▶; Paul et al., 2008 ▶; Minamino et al., 2011 ▶; Ibuki et al., 2013 ▶). Although crystal structures of FlhAC and FlhBC have been solved by X-ray crystallography (Bange et al., 2010 ▶; Meshcheryakov et al., 2013 ▶; Moore & Jia, 2010 ▶; Saijo-Hamano et al., 2010 ▶), it remains unknown how the export gate recognizes export substrates according to flagellar assembly and transports them in a Δψ-dependent manner.
FliP is a 25 kDa polytopic cytoplasmic membrane protein with a cleavable signal peptide at its N-terminus (Malakooti et al., 1994 ▶; Ohnishi et al., 1997 ▶). The Sec translocase and the YidC insertase mediate membrane insertion and topogenesis of FliP, and the signal peptide of FliP is cleaved during its membrane insertion, producing its mature form with a molecular weight of 23 kDa (Malakooti et al., 1994 ▶; Pradel et al., 2004 ▶, 2005 ▶; Ohnishi et al., 1997 ▶). The mature form of FliP is predicted to have four TM (transmembrane) helices and a periplasmic domain (FliPP) between TM-2 and TM-3. About four copies of FliP are estimated to be associated with the MS ring (Fan et al., 1997 ▶). FliP requires FliO for its protein stability in the cytoplasmic membrane (Barker et al., 2010 ▶). It has been reported that FliP interacts with FlhA (McMurry et al., 2004 ▶). These observations suggest that FliP forms a complex along with FliO and FlhA in the export apparatus. However, it remains unknown how FliP acts during flagellar protein export. In order to understand the role of FliP in the protein-export process, the atomic structure of FliP is essential. In this paper, we describe the expression, purification and crystallization of FliPP from the hyperthermophilic bacterium Thermotoga maritima.
2. Materials and methods
2.1. Protein expression and purification
A DNA fragment encoding FliPP (TmFliPP) consisting of residues 110–188 of T. maritima FliP (UniProt ID Q9WZG2) was generated by PCR with the plasmid pGS1-TmfliP (Gene Design Inc.) as a template and 5′-GGAATTCCATATGTACAACAATGCCATAACGCCG-3′ and 5′-CGCGGATCCTCATTTGAAGGCAACTTCCAGTTC-3′, containing NdeI and BamHI restriction sites, respectively, as primers. The amplified DNA fragment was purified using QIAquick PCR purification kits (Qiagen). The purified PCR product and the pET-15b vector were digested with NdeI and BamHI (New England Biolabs), gel-purified and ligated. The recombinant plasmids were isolated using QIAprep Spin Miniprep kits (Qiagen). The cloned DNA fragment was sequenced with a 3130 Genetic Analyzer (Applied Biosystems).
A 30 ml overnight culture of Escherichia coli strain BL21 (DE3) (Novagen) harbouring pKY045, which encodes TmFliPP with an N-terminal hexahistidine tag (His6) followed by a thrombin site (His6-TmFliPP; MGSS-6×His-SSGLVPRGSH-FliP) on pET-15b, was inoculated into 2.5 l LB medium (10 g l−1 Bacto tryptone, 5 g l−1 yeast extract, 10 g l−1 NaCl) containing 50 µg ml−1 ampicillin. Cells were grown at 303 K until the culture density had reached an OD600 of 0.4. Expression of His6-TmFliPP was induced with isopropyl β-d-1-thiogalactopyranoside (IPTG) at a final concentration of 0.4 mM, and the culture was incubated for a further 6 h. The cells were harvested by centrifugation (6400g, 10 min, 277 K) and stored at 193 K. The cells were thawed, suspended in buffer A (50 mM Tris–HCl pH 8.0, 300 mM NaCl) containing 20 mM imidazole and sonicated (Astrason model XL2020 sonicator, Misonix Inc.). The cell lysate was centrifuged (110 000g, 40 min, 277 K) to remove cell debris. The supernatant was loaded onto Ni–NTA agarose resin (Qiagen) equilibrated with buffer A containing 20 mM imidazole. The protein was then eluted with a 50–300 mM imidazole gradient in buffer A and fractions containing His6-TmFliPP were collected. The His6 tag was removed by adding 50 units of thrombin (GE Healthcare) to the His6-TmFliPP solution. The reaction mixture was dialyzed overnight at 277 K against buffer A with 200 mM imidazole followed by buffer A with 100 mM imidazole and finally buffer A with 20 mM imidazole. TmFliPP was purified using a HisTrap HP 5 ml column (GE Healthcare) to remove the N-terminally His-tagged polypeptide, noncleaved His6-TmFliPP and thrombin. The eluted fractions containing TmFliPP were concentrated using a Vivaspin 20 (30 000 MWCO, Sartorius), dialyzed overnight against buffer B (10 mM sodium phosphate pH 7.0, 100 mM NaCl) and loaded onto a HiLoad Superdex 75 (26/60) column (GE Healthcare) equilibrated with buffer B. Fractions containing TmFliPP were collected. The purity of the product was examined by SDS–PAGE and MALDI–TOF mass spectrometry (Voyager DE Pro, Applied Biosystems).
To purify a selenomethionine (SeMet) derivative of TmFliPP (SeMet-TmFliPP) for phase determination, we used E. coli B834 (DE3) strain (Novagen) as a host. Cells grown overnight in LB medium containing 50 mg l−1 ampicillin at 303 K were harvested by centrifugation (5000g, 5 min, 277 K), washed and suspended in 0.5%(w/v) NaCl. The cells were inoculated into SeMet minimal medium [1 g l−1 NH4Cl, 3 g l−1 KH2PO4, 8 g l−1 Na2HPO4.12H2O, 20 g l−1 glucose, 0.6 g l−1 MgSO4.7H2O, 10 mg l−1 Fe2(SO4)3, 10 mg−1 thiamine and 50 mg l−1 l-SeMet] (Guerrero et al., 2001 ▶; Sakane, 2008 ▶) supplemented with 50 mg l−1 ampicillin and grown at 310 K until the cell density reached an OD600 of 0.4. Expression of SeMet-labelled His6-TmFliPP was induced with 0.4 mM IPTG and the culture was continued for a further 4 h. The cells were harvested by centrifugation (6400g, 10 min, 277 K) and stored at 190 K. SeMet-TmFliPP was purified similarly to native TmFliPP. Incorporation of SeMet into TmFliPP was confirmed by MALDI–TOF mass spectrometry.
2.2. Analytical ultracentrifugation
Analytical ultracentrifugation was carried out using a Beckman Optima XL-A analytical ultracentrifuge with an An-60 Ti rotor. The protein samples were extensively dialyzed against buffer B prior to analytical ultracentrifugation. Sedimentation-equilibrium measurements were performed at 277 K at speeds of 22 000, 24 000 and 26 000 rev min−1 on a sample at an initial concentration of 0.85 mg ml−1 using a two-channel charcoal-filled epon centrepiece and quartz windows. Scans were collected at a wavelength of 280 nm at a spacing of 0.001 cm in step mode with 20 averages per step. The equilibrium of the system was judged by superimposition of the three scans. Sedimentation-equilibrium data of TmFliPP, the partial specific volume
of which was calculated to be 0.736 ml g−1 from the amino-acid composition of the protein, were analyzed to obtain the average molecular weight using the Optima XL-A/XLI software v.04.
2.3. Crystallization
Purified TmFliPP was concentrated and passed through a 0.20 µm Millex-LG syringe filter (Millipore). The protein concentration was estimated based on an A 280 of 0.47 for a 1 mg ml−1 solution. Initial crystallization screening of TmFliPP was performed at 277 and 293 K by the sitting-drop vapour-diffusion technique using NeXtal Evolution plates (Qiagen) and the following screening kits: Wizard Classic 1 and 2, Wizard Cryo 1 and 2 (Rigaku), Crystal Screen and Crystal Screen 2 (Hampton Research). Each drop was prepared by mixing 1.0 µl protein solution (20 mg ml−1 TmFliPP, 10 mM sodium phosphate pH 7.0, 100 mM NaCl) with 1.0 µl reservoir solution and was equilibrated against 60 µl reservoir solution. The crystallization conditions were optimized by varying the precipitant concentration, pH and additives using the hanging-drop method with VDX plates (Hampton Research). Finally, crystals suitable for X-ray analysis were obtained from drops prepared by mixing 1.5 µl protein solution (5 mg ml−1) with 1.5 µl reservoir solution consisting of 0.1 M phosphate–citrate pH 4.4, 36% 2-methyl-2,4-pentanediol (MPD) at 277 K within a week.
2.4. Data collection and processing
All X-ray diffraction data were collected on beamline BL41XU at SPring-8, Harima, Japan. Crystals were mounted in nylon CryoLoops (Hampton Research). Because the concentration of MPD in the crystallization drops was high enough for cryoprotection, the crystals were directly transferred into liquid nitrogen for freezing. The diffraction data were recorded on an MX225HE CCD detector (Rayonix) at 100 K using a nitrogen-gas flow to reduce radiation damage. The diffraction data were indexed, integrated and scaled using iMosflm (Battye et al., 2011 ▶) and SCALA (Evans, 2006 ▶) from the CCP4 program suite (Winn et al., 2011 ▶). The statistics of data collection are summarized in Table 1 ▶.
Table 1. Summary of the data statistics.
Values in parentheses are for the highest resolution shell.
| Native | SeMet derivative | |
|---|---|---|
| Space group | P6222 or P6422 | P6222 or P6422 |
| Unit-cell parameters | ||
| a = b (Å) | 114.9 | 115.3 |
| c (Å) | 193.8 | 193.6 |
| α = β (°) | 90 | 90 |
| γ (°) | 120 | 120 |
| Wavelength (Å) | 1.0 | 0.9791 |
| Resolution (Å) | 43.6–2.4 (2.53–2.40) | 43–2.8 (2.95–2.80) |
| No. of observed reflections | 214552 | 257930 |
| No. of unique reflections | 30262 | 18573 |
| R merge † | 0.088 (0.357) | 0.097 (0.23) |
| R ano ‡ | 0.053 (0.12) | |
| Mean I/σ(I) | 13.5 (5.5) | 17.0 (5.4) |
| Completeness (%) | 99.9 (100.0) | 95.1 (67.6) |
| Multiplicity | 7.1 (7.2) | 7.5 (2.4) |
R
merge =
, where Ii(hkl) is the ith observation of reflection hkl and 〈I(hkl)〉 is the weighted average intensity for all i observations of reflection hkl.
R
ano =
, where 〈I(hkl+)〉 and 〈I(hkl−)〉 correspond to the average intensities of each Friedel pair for reflection hkl.
3. Results and discussion
To carry out high-resolution structural analysis of TmFliP, we first focused on FliPP because overexpression of full-length FliP totally inhibited the growth of E. coli cells (data not shown). A topological model of FliP derived from Salmonella enterica serovar Typhimurium (UniProt ID P54700) has been proposed (Ohnishi et al., 1997 ▶). Sequence alignment between TmFliP and Salmonella FliP allowed us to identify residues 110–188 in TmFliP as TmFliPP. E. coli BL21(DE3) cells were transformed with pKY045, which encodes His6-TmFliPP on pET-15b, and cell lysates were prepared from the resulting transformants. The soluble fraction containing His6-TmFliPP was loaded onto an Ni–NTA column and purified. Because His6-TmFliPP tended to form aggregates on rapid removal of imidazole during dialysis, imidazole was slowly removed by stepwise dialysis. After removal of the His6 tag by thrombin, TmFliPP was purified by Ni-affinity chromatography followed by size-exclusion chromatography. The elution profile from size-exclusion chromatography indicated that the purified TmFliPP is in an oligomeric state (data not shown). To determine the oligomeric state, we carried out sedimentation-equilibrium analytical ultracentrifugation. A single-species model with a molecular weight of 39.7 kDa produced the best fit (Fig. 1 ▶). Because the deduced molecular weight of TmFliPP is 9553.9 Da, this indicates that TmFliPP forms a homotetramer in solution. However, some of the tetramers dissociated into dimers a few days later. To stabilize the tetramer, we varied the pH and the NaCl concentration and found that the tetramer is quite stable at a pH below 7.0. This is consistent with our observation that no crystals grew from a purified TmFliPP sample stored at pH 8.0. As a result, TmFliPP crystals were successfully grown from a solution consisting of 0.1 M phosphate–citrate pH 4.4, 36% MPD at 277 K (Fig. 2 ▶ a). The TmFliPP crystals diffracted to 2.4 Å resolution (Fig. 2 ▶ b) and belonged to the hexagonal space group P6222 or P6422, with unit-cell parameters a = b = 114.9, c = 193.8 Å, α = β = 90.0, γ = 120.0° (Table 1 ▶). Calculation of the Matthews coefficient (V M; Matthews, 1968 ▶) suggests that the asymmetric unit contains between six and 11 molecules with solvent contents of between 62% (V M = 3.24 Å3 Da−1) and 31% (V M = 1.77 Å3 Da−1).
Figure 1.
Sedimentation-equilibrium analysis of TmFliPP. The initial protein concentration was 0.85 mg ml−1. Open circles are data points and the solid line is a model fit. Data points are fitted to a single-species model with a molecular mass of 39.7 kDa. Measurements were taken at 277 K.
Figure 2.
(a) Crystals of native TmFliPP. Crystals obtained using 36% MPD, 0.1 M phosphate–citrate pH 4.4. (b) Diffraction image of the TmFliPP crystal grown from the optimized condition. A typical X-ray pattern of the TmFliPP crystal collected on beamline BL41XU at SPring-8. The inset shows a close-up view of the diffraction image. (c) Bijvoet difference Patterson map at w = 0.33 Harker section calculated from the TmFliPp SeMet-derivative data at 3.5 Å resolution. The contour lines are drawn from 2.0σ to 6.0σ with an increment of 0.5σ.
SeMet-TmFliPP crystals were obtained under the same condition as the native TmFliPP crytals. The shape and size of the SeMet-TmFliPP crystals were almost the same as thoose of the native crystals. The SeMet-TmFliPP crystals diffracted to 2.8 Å resolution. The unit-cell parameters of the derivative crystals (a = b = 115.3, c = 193.6 Å, α = β = 90.0, γ = 120.0°) were almost the same as those of the native crystals (Table 1 ▶). Anomalous dispersion difference Patterson maps of the SeMet derivative showed significant peaks on the Harker section (Fig. 2 ▶ c), suggesting the usefulness of these data for phasing by the SAD method.
Acknowledgments
We acknowledge Dr K. Hasegawa at SPring-8 for technical help with the use of beamline BL41XU. This work was supported in part by JSPS KAKENHI grant Nos. 24570132 (to YS-H), 21227006 and 25000013 (to KN) and 26293097 (to TM) and MEXT KAKENHI grant Nos. 2312516 (to TM) and 23115008 (to KI and TM).
References
- Abrusci, P., Vergara-Irigaray, M., Johnson, S., Beeby, M. D., Hendrixson, D. R., Roversi, P., Friede, M. E., Deane, J. E., Jensen, G. J., Tang, C. M. & Lea, S. M. (2013). Nature Struct. Mol. Biol. 20, 99–104. [DOI] [PMC free article] [PubMed]
- Bange, G., Kümmerer, N., Engel, C., Bozkurt, G., Wild, K. & Sinning, I. (2010). Proc. Natl Acad. Sci. USA, 107, 11295–11300. [DOI] [PMC free article] [PubMed]
- Barker, C. S., Meshcheryakova, I. V., Kostyukova, A. S. & Samatey, F. A. (2010). PLoS Genet. 6, e1001143. [DOI] [PMC free article] [PubMed]
- Battye, T. G. G., Kontogiannis, L., Johnson, O., Powell, H. R. & Leslie, A. G. W. (2011). Acta Cryst. D67, 271–281. [DOI] [PMC free article] [PubMed]
- Evans, P. (2006). Acta Cryst. D62, 72–82. [DOI] [PubMed]
- Fan, F., Ohnishi, K., Francis, N. R. & Macnab, R. M. (1997). Mol. Microbiol. 82, 1035–1046. [DOI] [PubMed]
- Guerrero, S. A., Hecht, H. J., Hofmann, B., Biebl, H. & Singh, M. (2001). Appl. Microbiol. Biotechnol. 56, 718–723. [DOI] [PubMed]
- Hirano, T., Mizuno, S., Aizawa, S. & Hughes, K. T. (2009). J. Bacteriol. 19, 3938–3949. [DOI] [PMC free article] [PubMed]
- Ibuki, T., Imada, K., Minamino, T., Kato, T., Miyata, T. & Namba, K. (2011). Nature Struct. Mol. Biol. 18, 277–282. [DOI] [PubMed]
- Ibuki, T., Uchida, Y., Hironaka, Y., Namba, K., Imada, K. & Minamino, T. (2013). J. Bacteriol. 195, 466–473. [DOI] [PMC free article] [PubMed]
- Imada, K., Minamino, T., Tahara, A. & Namba, K. (2007). Proc. Natl Acad. Sci. USA, 104, 131–137. [DOI] [PMC free article] [PubMed]
- Kawamoto, A., Morimoto, Y. V., Miyata, T., Minamino, T., Hughes, K. T., Kato, T. & Namba, K. (2013). Sci Rep. 3, 3369. [DOI] [PMC free article] [PubMed]
- Kinoshita, M., Hara, N., Imada, K., Namba, K. & Minamino, T. (2013). Mol. Microbiol. 90, 1249–1261. [DOI] [PubMed]
- Kishikawa, J., Ibuki, T., Nakamura, S., Nakanishi, A., Minamino, T., Miyata, T., Namba, K., Konno, H., Ueno, H., Imada, K. & Yokoyama, K. (2013). PLoS One, 8, e64695. [DOI] [PMC free article] [PubMed]
- Macnab, R. M. (2004). Biochim. Biophys. Acta, 1694, 207–217. [DOI] [PubMed]
- Malakooti, J., Ely, B. & Matsumura, P. (1994). J. Bacteriol. 176, 189–197. [DOI] [PMC free article] [PubMed]
- Matthews, B. W. (1968). J. Mol. Biol. 33, 491–497. [DOI] [PubMed]
- McMurry, J. L., Van Arnam, J. S., Kihara, M. & Macnab, R. M. (2004). J. Bacteriol. 186, 7586–7592. [DOI] [PMC free article] [PubMed]
- Meshcheryakov, V. A., Kitao, A., Matsunami, H. & Samatey, F. A. (2013). Acta Cryst. D69, 812–820. [DOI] [PMC free article] [PubMed]
- Minamino, T. (2013). Biochim. Biophys. Acta, 1843, 1642–1648. [DOI] [PubMed]
- Minamino, T., González-Pedrajo, B., Kihara, M., Namba, K. & Macnab, R. M. (2003). J. Bacteriol. 185, 3983–3988. [DOI] [PMC free article] [PubMed]
- Minamino, T., Imada, K. & Namba, K. (2008). Mol. Biosyst. 4, 1105–1115. [DOI] [PubMed]
- Minamino, T. & MacNab, R. M. (2000). Mol. Microbiol. 35, 1052–1064. [DOI] [PubMed]
- Minamino, T., Morimoto, Y. V., Hara, N. & Namba, K. (2011). Nature Commun. 2, 475. [DOI] [PMC free article] [PubMed]
- Minamino, T. & Namba, K. (2004). J. Mol. Microbiol. Biotechnol. 7, 5–17. [DOI] [PubMed]
- Minamino, T. & Namba, K. (2008). Nature (London), 451, 485–488. [DOI] [PubMed]
- Moore, S. A. & Jia, Y. (2010). J. Biol. Chem. 285, 21060–21069. [DOI] [PMC free article] [PubMed]
- Morimoto, Y. V., Ito, M., Hiraoka, K. D., Che, Y.-S., Bai, F., Kami-ike, N., Namba, K. & Minamino, T. (2014). Mol. Microbiol. 91, 1214–1226. [DOI] [PubMed]
- Ohnishi, K., Fan, F., Schoenhals, G. J., Kihara, M. & Macnab, R. M. (1997). J. Bacteriol. 179, 6092–6099. [DOI] [PMC free article] [PubMed]
- Paul, K., Erhardt, M., Hirano, T., Blair, D. F. & Hughes, K. T. (2008). Nature (London), 451, 489–492. [DOI] [PubMed]
- Pradel, N., Decorps, A., Ye, C., Santini, C. L. & Wu, L.-F. (2005). Biochimie, 87, 191–196. [DOI] [PubMed]
- Pradel, N., Ye, C. & Wu, L.-F. (2004). Biochem. Biophys. Res. Commun. 319, 1276–1280. [DOI] [PubMed]
- Saijo-Hamano, Y., Imada, K., Minamino, T., Kihara, M., Shimada, M., Kitao, A. & Namba, K. (2010). Mol. Microbiol. 76, 260–268. [DOI] [PubMed]
- Sakane, I. (2008). PSSJ Arch. 1, e004.
- Winn, M. D. et al. (2011). Acta Cryst. D67, 235–242.


